Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.42 |
| ▸ | FDPS | P14324 | 4/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | LAP3 | P28838 | 1/20 | 0.39 |
| ▸ | SGPL1 | O95470 | 4/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7859709 | 1.00 | CYP3A4 (0.65) | CYP3A4L3MBTL1TSHRSMPD1FDPS | |
| SCHEMBL29703287 | 1.00 | CYP3A4 (0.65) | CYP3A4L3MBTL1TSHRSMPD1FDPS | |
| SCHEMBL22844445 | 1.00 | CYP3A4 (0.65) | CYP3A4L3MBTL1TSHRSMPD1FDPS | |
| SCHEMBL7942552 | 0.94 | CYP3A4 (0.71) | CYP3A4L3MBTL1TSHRSMPD1FDPS | |
| SCHEMBL8564175 | 0.94 | CYP3A4 (0.71) | CYP3A4L3MBTL1TSHRSMPD1FDPS | |
| SCHEMBL10901321 | 0.94 | CYP3A4 (0.71) | CYP3A4L3MBTL1TSHRSMPD1FDPS | |
| SCHEMBL10902137 | 0.94 | CYP3A4 (0.71) | CYP3A4L3MBTL1TSHRSMPD1FDPS | |
| SCHEMBL7859644 | 0.93 | CYP3A4 (0.57) | CYP3A4L3MBTL1TSHRSMPD1LMNA | |
| SCHEMBL1986718 | 0.92 | CYP3A4 (0.75) | CYP3A4L3MBTL1TSHRSMPD1FDPS | |
| SCHEMBL3331725 | 0.89 | CYP3A4 (0.69) | CYP3A4L3MBTL1TSHRSMPD1FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6299887-B1 | USED IN COSMETICS | KAO CORPORATION (JP) | 2001-10-09 | — | — | US | disclosed |